Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Dyspnoea, Fatigue, Illness, Inappropriate schedule of product administration
Clinical narrative: Cannot go to work due to severe pain; Cannot move; In so much pain/Severe pain; Wheezing; Cold sweats/Breaks out in cold sweats; Hard time breathing/difficulty breathing; Being in bed all day; No energy; Does not have much of an appetite; Anxiety (anxious); Sick for a whole week; Severe body aches; Fatigue; Chills; Fever; 2nd dose received on 28Jul2021/1st dose received on 15Apr2021; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Cannot go to work due to severe pain), MOBILITY DECREASED (Cannot move), PAIN (In so much pain/Severe pain), WHEEZING (Wheezing) and COLD SWEAT (Cold sweats/Breaks out in cold sweats) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051C21A and 040B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.   On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received on 28Jul2021/1st dose received on 15Apr2021). On an unknown date, the patient experienced LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Cannot go to work due to severe pain), MOBILITY DECREASED (Cannot move), PAIN (In so much pain/Severe pain), WHEEZING (Wheezing), COLD SWEAT (Cold sweats/Breaks out in cold sweats), DYSPNOEA (Hard time breathing/difficulty breathing), BEDRIDDEN (Being in bed all day), ASTHENIA (No energy), DECREASED APPETITE (Does not have much of an appetite), ANXIETY (Anxiety (anxious)), ILLNESS (Sick for a whole week), MYALGIA (Severe body aches), FATIGUE (Fatigue), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency and CLONAZEPAM for Anxiety, at an unspecified dose and frequency. On 28-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received on 28Jul2021/1st dose received on 15Apr2021) had resolved. At the time of the report, LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (Cannot go to work due to severe pain), MOBILITY DECREASED (Cannot move), MYALGIA (Severe body aches) and FATIGUE (Fatigue) had not resolved and PAIN (In so much pain/Severe pain), WHEEZING (Wheezing), COLD SWEAT (Cold sweats/Breaks out in cold sweats), DYSPNOEA (Hard time breathing/difficulty breathing), BEDRIDDEN (Being in bed all day), ASTHENIA (No energy), DECREASED APPETITE (Does not have much of an appetite), ANXIETY (Anxiety (anxious)), ILLNESS (Sick for a whole week), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown.            Patient still experiencing fatigue, severe body aches to the point where she cannot move and cannot go to work due to severe pain.